HLA-G: a shield against inflammatory aggression (Q33954904)

30 July 2017

1 reference

title

HLA-G: a shield against inflammatory aggression (English)

1 reference

ORCID Public Data File 2021

30 July 2017

0 references

1 reference

Edgardo D. Carosella

series ordinal

object named as

Carosella ED

1 reference

30 July 2017

Nathalie Rouas-Freiss

series ordinal

object named as

Rouas-Freiss N

1 reference

30 July 2017

Moreau P

1 reference

30 July 2017

Aractingi S

series ordinal

1 reference

30 July 2017

publication date

1 October 2001

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

553-555

1 reference

Proinflammatory cytokines

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

Anti-inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

Glucocorticoids drive human CD8(+) T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

HLA-G and HLA-E: fundamental and Pathophysiological aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

HLA-G inhibits the transendothelial migration of human NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

HLA-G inhibits the allogeneic proliferative response

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

HLA-G suppresses proliferation of CD4(+) T-lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

Implication of HLA-G molecule in heart-graft acceptance.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

HLA-G expression: immune privilege for tumour cells?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

HLA-G Expression in Atopic Dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

Soluble HLA-G in human placentas: synthesis in trophoblasts and interferon-gamma-activated macrophages but not placental fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

Molecular mechanisms controlling constitutive and IFN-gamma-inducible HLA-G expression in various cell types.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

A Specific Interferon (IFN)-stimulated Response Element of the Distal HLA-G Promoter Binds IFN-regulatory Factor 1 and Mediates Enhancement of This Nonclassical Class I Gene by IFN-β

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

Role of chemokines in inflammation and immunoregulation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

HLA-G has a concentration-dependent effect on the generation of an allo-CTL response

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

HLA-G expression during preimplantation human embryo development

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

Primate Mhc-E and -G alleles

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

HLA-G1 protein expression is not essential for fetal survival

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

Homozygous HLA-G*0105N healthy individuals indicate that membrane-anchored HLA-G1 molecule is not necessary for survival

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

Th 1-type immunity is incompatible with successful pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2801%2902007-5

7 January 2021

10.1016/S1471-4906(01)02007-5

Identifiers

DOI

1 reference

30 July 2017

1 reference